TYRA BIOSCIENCES INC's ticker is and the CUSIP is 90240B106. A total of 60 filers reported holding TYRA BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,494 | -46.4% | 3,086 | -33.7% | 0.00% | – |
| Q2 2023 | $79,224 | -0.0% | 4,652 | -5.6% | 0.00% | – |
| Q1 2023 | $79,225 | +88.8% | 4,930 | -10.7% | 0.00% | – |
| Q4 2022 | $41,967 | -8.8% | 5,522 | +6.6% | 0.00% | – |
| Q3 2022 | $46,000 | +15.0% | 5,180 | -7.7% | 0.00% | – |
| Q2 2022 | $40,000 | -25.9% | 5,612 | +10.8% | 0.00% | – |
| Q1 2022 | $54,000 | -42.6% | 5,064 | -24.0% | 0.00% | – |
| Q4 2021 | $94,000 | – | 6,665 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 4,409,991 | $31,531,000 | 11.23% |
| Nextech Invest Ltd. | 2,518,582 | $18,008,000 | 6.07% |
| Boxer Capital, LLC | 6,448,359 | $46,106,000 | 2.92% |
| TCG Crossover Management, LLC | 896,418 | $6,409,000 | 2.72% |
| Fairmount Funds Management LLC | 1,416,998 | $10,132,000 | 2.32% |
| RA Capital Management | 7,236,454 | $51,741,000 | 1.38% |
| Frazier Life Sciences Management, L.P. | 1,375,065 | $9,832,000 | 0.93% |
| BVF INC/IL | 2,472,327 | $17,677,000 | 0.85% |
| Sio Capital Management, LLC | 152,159 | $1,088,000 | 0.41% |
| Cormorant Asset Management, LP | 743,988 | $5,320,000 | 0.40% |